TR200201245T2 - Kanser tedavisi için onkolitik kombinasyonlar. - Google Patents

Kanser tedavisi için onkolitik kombinasyonlar.

Info

Publication number
TR200201245T2
TR200201245T2 TR2002/01245T TR200201245T TR200201245T2 TR 200201245 T2 TR200201245 T2 TR 200201245T2 TR 2002/01245 T TR2002/01245 T TR 2002/01245T TR 200201245 T TR200201245 T TR 200201245T TR 200201245 T2 TR200201245 T2 TR 200201245T2
Authority
TR
Turkey
Prior art keywords
cancer treatment
oncolytic
combinations
oncolytic combinations
ltb4
Prior art date
Application number
TR2002/01245T
Other languages
English (en)
Turkish (tr)
Inventor
Herbert Fleisch Jerome
Stuart Benjamin Roger
Scott Sawyer Jason
Ann Teicher Beverly
Wade Beight Douglas
C. R. Smith Edward
Thomas Mcmillen William
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200201245T2 publication Critical patent/TR200201245T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
TR2002/01245T 1999-11-11 2000-11-09 Kanser tedavisi için onkolitik kombinasyonlar. TR200201245T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11

Publications (1)

Publication Number Publication Date
TR200201245T2 true TR200201245T2 (tr) 2004-08-23

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01245T TR200201245T2 (tr) 1999-11-11 2000-11-09 Kanser tedavisi için onkolitik kombinasyonlar.

Country Status (22)

Country Link
EP (1) EP1231938A2 (es)
JP (1) JP2003513916A (es)
KR (1) KR20020069512A (es)
CN (1) CN1390139A (es)
AR (1) AR032432A1 (es)
AU (1) AU778829B2 (es)
BR (1) BR0015490A (es)
CA (1) CA2391416A1 (es)
CZ (1) CZ20021551A3 (es)
EA (1) EA200200545A1 (es)
HK (1) HK1050132A1 (es)
HU (1) HUP0204449A3 (es)
IL (1) IL148579A0 (es)
MX (1) MXPA02004733A (es)
NO (1) NO20022245L (es)
NZ (1) NZ517667A (es)
PE (1) PE20010701A1 (es)
PL (1) PL355172A1 (es)
SK (1) SK6492002A3 (es)
TR (1) TR200201245T2 (es)
WO (1) WO2001034137A2 (es)
ZA (1) ZA200202822B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1916501A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
AU1916601A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
CN1237968C (zh) * 2000-05-09 2006-01-25 克赖顿大学 抑制癌细胞的增殖和诱导其凋亡的方法
JP2004505047A (ja) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
EP1745014B1 (en) 2004-05-05 2011-07-06 High Point Pharmaceuticals, LLC Novel compounds, their preparation and use
JP2007536343A (ja) 2004-05-05 2007-12-13 ノボ　ノルディスク　アクティーゼルスカブ Ｐｐａｒアゴニストとしてのフェノキシ酢酸誘導体
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
ATE529404T1 (de) 2005-06-30 2011-11-15 High Point Pharmaceuticals Llc Phenoxyessigsäuren als ppar-delta-aktivatoren
EA015717B1 (ru) 2005-12-22 2011-10-31 ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Феноксиуксусные кислоты в качестве активаторов ppar дельта
EP1999098A2 (en) 2006-03-09 2008-12-10 High Point Pharmaceuticals, LLC Compounds that modulate ppar activity, their preparation and use
US8044236B2 (en) 2006-10-12 2011-10-25 Institute Of Medicinal Molecular Design, Inc. Carboxilic acid derivatives
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
CN104884449A (zh) 2012-10-31 2015-09-02 拜尔农作物科学股份公司 作为害虫防治剂的新的杂环化合物
CN103319466B (zh) * 2013-07-04 2016-03-16 郑州大学 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
EA200200545A1 (ru) 2002-12-26
CA2391416A1 (en) 2001-05-17
NZ517667A (en) 2004-05-28
WO2001034137A3 (en) 2002-02-14
KR20020069512A (ko) 2002-09-04
HK1050132A1 (zh) 2003-06-13
CZ20021551A3 (cs) 2003-02-12
AU1599001A (en) 2001-06-06
MXPA02004733A (es) 2002-08-30
WO2001034137A2 (en) 2001-05-17
AU778829B2 (en) 2004-12-23
CN1390139A (zh) 2003-01-08
NO20022245D0 (no) 2002-05-10
HUP0204449A2 (hu) 2003-04-28
PL355172A1 (en) 2004-04-05
EP1231938A2 (en) 2002-08-21
NO20022245L (no) 2002-07-09
BR0015490A (pt) 2002-07-09
IL148579A0 (en) 2002-09-12
AR032432A1 (es) 2003-11-12
PE20010701A1 (es) 2001-07-07
ZA200202822B (en) 2003-09-23
HUP0204449A3 (en) 2006-02-28
SK6492002A3 (en) 2003-09-11
JP2003513916A (ja) 2003-04-15

Similar Documents

Publication Publication Date Title
TR200201245T2 (tr) Kanser tedavisi için onkolitik kombinasyonlar.
BR0216099B1 (pt) "conjunto de desgaste".
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
ATE293618T1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
BR0207378A (pt) Tratamento de câncer
DE69925133D1 (de) Pyrrolobenzodiazepine
ATE415979T1 (de) Behandlung mit anti-erbb2 antikörpern
DE60112974D1 (en) Carbolinderivate
ATE355278T1 (de) Isochinolinon derivate als parp inhibitoren
ATE231872T1 (de) Thiazolopyrimidinderivate
ZA993345B (en) Nefazodone dosage form.
DE60216233D1 (en) Carbolinderivate
NO20040516L (no) Kombinasjonsterapi for behandling av kreft.
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
WO2001034198A3 (en) Oncolytic combinations for the treatment of cancer
DE60112960D1 (de) Kondensierte pyridoindolderivate
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
DK1204659T3 (da) Serotonerge benzofuraner
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
WO2001034134A3 (en) Oncolytic combinations for the treatment of cancer
TR199901017A2 (xx) B�cek ilac� terkibi.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
ZA200205470B (en) Virus strains for the oncolytic treatment of cancer.
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav